Adalimumab as treatment for neurosarcoidosis: A case series.
Publication
, Journal Article
Shen, J; Sugita, M; Linares-Lopez, A; Shah, S; Eckstein, C; Lackey, E
Published in: J Neurol Sci
May 15, 2024
Sarcoidosis is a disease characterized by non-caseating granulomas that can involve the central nervous system as neurosarcoidosis. This challenging disease is currently managed with high dose steroids, and sometimes the addition of infliximab. Other TNA-alpha inhibitors have not been studied as rigorously. We discovered ten neurosarcoidosis patients who were on an alternative TNA-alpha inhibitor, adalimumab. Eight patients had a positive response clinically and radiographically to adalimumab.
Duke Scholars
Published In
J Neurol Sci
DOI
EISSN
1878-5883
Publication Date
May 15, 2024
Volume
460
Start / End Page
123018
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Sarcoidosis
- Middle Aged
- Male
- Humans
- Female
- Central Nervous System Diseases
- Anti-Inflammatory Agents
- Aged
- Adult
Citation
APA
Chicago
ICMJE
MLA
NLM
Shen, J., Sugita, M., Linares-Lopez, A., Shah, S., Eckstein, C., & Lackey, E. (2024). Adalimumab as treatment for neurosarcoidosis: A case series. J Neurol Sci, 460, 123018. https://doi.org/10.1016/j.jns.2024.123018
Shen, Jeffrey, Megumi Sugita, Andrea Linares-Lopez, Suma Shah, Christopher Eckstein, and Elijah Lackey. “Adalimumab as treatment for neurosarcoidosis: A case series.” J Neurol Sci 460 (May 15, 2024): 123018. https://doi.org/10.1016/j.jns.2024.123018.
Shen J, Sugita M, Linares-Lopez A, Shah S, Eckstein C, Lackey E. Adalimumab as treatment for neurosarcoidosis: A case series. J Neurol Sci. 2024 May 15;460:123018.
Shen, Jeffrey, et al. “Adalimumab as treatment for neurosarcoidosis: A case series.” J Neurol Sci, vol. 460, May 2024, p. 123018. Pubmed, doi:10.1016/j.jns.2024.123018.
Shen J, Sugita M, Linares-Lopez A, Shah S, Eckstein C, Lackey E. Adalimumab as treatment for neurosarcoidosis: A case series. J Neurol Sci. 2024 May 15;460:123018.
Published In
J Neurol Sci
DOI
EISSN
1878-5883
Publication Date
May 15, 2024
Volume
460
Start / End Page
123018
Location
Netherlands
Related Subject Headings
- Treatment Outcome
- Sarcoidosis
- Middle Aged
- Male
- Humans
- Female
- Central Nervous System Diseases
- Anti-Inflammatory Agents
- Aged
- Adult